Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $4.40 and traded as high as $4.47. Evotec shares last traded at $4.39, with a volume of 57,649 shares changing hands.
Evotec Trading Down 3.9 %
The business has a 50 day simple moving average of $4.40 and a 200-day simple moving average of $4.20. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57. The stock has a market capitalization of $1.39 billion, a P/E ratio of 10.29 and a beta of 0.98.
Evotec Company Profile
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
- Five stocks we like better than Evotec
- Manufacturing Stocks Investing
- Chaos and Cash: Finding Opportunity in Volatility
- Business Services Stocks Investing
- Realty Income: An Anchor in Volatile Markets
- What Does a Stock Split Mean?
- Autodesk Designs Value for Investors: Uptrend Set to Continue
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.